Recruiting Myelodysplastic Syndromes Studies in Chapel Hill
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy and safety of AK117 or placebo, combined with azacitidine in patients with newly diagnosed hig...
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
This study will enroll participants with myelodysplastic syndromes (MDS) with an Isocitrate dehydrogenase protein, 1 (IDH1) mutation, who have not received treatment with a hypomethylating agent previ...
About Myelodysplastic Syndromes Clinical Trials in Chapel Hill
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
There are currently 2 myelodysplastic syndromes clinical trials recruiting participants in Chapel Hill, NORTH%20CAROLINA. These studies are seeking a combined 138 participants. Research is being sponsored by Akeso, Institut de Recherches Internationales Servier. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelodysplastic Syndromes Clinical Trials in Chapel Hill — FAQ
Are there myelodysplastic syndromes clinical trials in Chapel Hill?
Yes, there are 2 myelodysplastic syndromes clinical trials currently recruiting in Chapel Hill, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chapel Hill?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.
Are clinical trials in Chapel Hill free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.
What myelodysplastic syndromes treatments are being tested?
The 2 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for myelodysplastic syndromes.
Data updated March 2, 2026 from ClinicalTrials.gov